NLS Pharmaceutics AG - ESG Rating & Company Profile powered by AI
This ESG score covers 17 United Nations Sustainable Development Goals including: 'Good Health & Wellbeing', 'Reduced Inequalities' and 'Partnerships for the Goals'. The assessment of NLS Pharmaceutics AG is prepared by All Street Sevva using cutting edge NLP. Comprehensive Sustainability analysis of NLS Pharmaceutics AG are reached by signing in.
NLS Pharmaceutics AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 0.0, social score of 5.3 and governance score of 5.3.
3.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1144 | Veerhealth Care Ltd | 3.6 | Medium |
| 1144 | iStreet Network Ltd | 3.6 | Medium |
| 1186 | NLS Pharmaceutics AG | 3.5 | Medium |
| 1186 | CRISPR Therapeutics AG | 3.5 | Medium |
| 1186 | Catalent Inc | 3.5 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does NLS Pharmaceutics AG have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose current and historical energy intensity?
Sign up for free to unlockDoes NLS Pharmaceutics AG report the average age of the workforce?
Sign up for free to unlockDoes NLS Pharmaceutics AG reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose its ethnicity pay gap?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose cybersecurity risks?
Sign up for free to unlockDoes NLS Pharmaceutics AG offer flexible work?
Sign up for free to unlockDoes NLS Pharmaceutics AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose the number of employees in R&D functions?
Sign up for free to unlockDoes NLS Pharmaceutics AG conduct supply chain audits?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes NLS Pharmaceutics AG conduct 360 degree staff reviews?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose the individual responsible for D&I?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose water use targets?
Sign up for free to unlockDoes NLS Pharmaceutics AG have careers partnerships with academic institutions?
Sign up for free to unlockDid NLS Pharmaceutics AG have a product recall in the last two years?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose incidents of discrimination?
Sign up for free to unlockDoes NLS Pharmaceutics AG allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas NLS Pharmaceutics AG issued a profit warning in the past 24 months?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose parental leave metrics?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose the pay ratio of women to men?
Sign up for free to unlockDoes NLS Pharmaceutics AG support suppliers with sustainability related research and development?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes NLS Pharmaceutics AG reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs NLS Pharmaceutics AG involved in embryonic stem cell research?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose its waste policy?
Sign up for free to unlockDoes NLS Pharmaceutics AG report according to TCFD requirements?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose energy use targets?
Sign up for free to unlockDoes NLS Pharmaceutics AG disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes NLS Pharmaceutics AG have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for NLS Pharmaceutics AG
These potential risks are based on the size, segment and geographies of the company.
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its two lead product candidates, include Quilience, for the treatment of excessive daytime sleepiness and cataplexy; and Nolazol, for the treatment of ADHD. NLS Pharmaceutics AG was founded in 2015 and is based in Stans, Switzerland.